Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Is a |
Amidotrizoate-containing product |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Amidotrizoate |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Is a |
Product containing iodine AND/OR iodine compound |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Is a |
Product containing meglumine diatrizoate |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Iodine |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Meglumine amidotrizoate |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Iodine compound |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
iode et/ou composé iodé |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Is a |
Product manufactured as parenteral dose form (product) |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Has manufactured dose form |
Solution for injection |
false |
Inferred relationship |
Some |
|
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
Is a |
Product containing meglumine diatrizoate in parenteral dose form (medicinal product form) |
false |
Inferred relationship |
Some |
|
|